Skip to content

Clinical trials

Cholangiocarcinoma trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Country / region: Netherlands Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20142
20153
20162
20172
20181
20192
20201
20213
20224
20234
20242
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting10
Active, not recruiting5
Terminated3
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Erasmus Medical Center3
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)2
Amsterdam UMC, location VUmc2
Hoffmann-La Roche2
Merck Sharp & Dohme LLC2
Alentis Therapeutics AG1
Amgen1
Bayer1
Boston Scientific Corporation1
Elevar Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma31
Pancreatic Neoplasms5
Breast Neoplasms4
Carcinoma, Hepatocellular4
Klatskin Tumor4
Ovarian Neoplasms4
Colorectal Neoplasms3
Gallbladder Neoplasms3
Glioma3
Stomach Neoplasms3

Trials

Showing 76 to 31 of 31. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.